Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
44.60
+0.30 (0.68%)
May 13, 2025, 11:40 AM CET

Basilea Pharmaceutica AG Market Cap

Basilea Pharmaceutica AG has a market cap or net worth of 537.37 million as of May 13, 2025. Its market cap has increased by 8.53% in one year.

Market Cap
537.37M
Enterprise Value
528.33M
Revenue
208.54M
Ranking
n/a
PE Ratio
7.61
Stock Price
44.60

Market Cap Chart

Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 537.37M, an increase of 0.76%. That is a compound annual growth rate of 0.04%.

History

DateMarket Cap% Change
May 12, 2025537.37M7.22%
Dec 30, 2024501.21M18.52%
Dec 29, 2023422.90M-22.52%
Dec 30, 2022545.84M12.62%
Dec 30, 2021484.67M-15.59%
Dec 30, 2020574.19M14.12%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Roche Holding AG 207.01B
Novartis AG 178.12B
Lonza Group AG 41.31B
Alcon 39.48B
Galderma Group AG 23.68B
Straumann Holding AG 17.05B
Sandoz Group AG 16.38B
Sonova Holding AG 15.62B
Market Cap Rankings